Actualisation des Recommandations de la Société française de rhumatologie pour la prise en charge de la polyarthrite rhumatoïde

…, A Saraux, G Thibaud, D Wendling, L Gossec… - Revue du …, 2019 - Elsevier
Les précédentes recommandations de 2014 ont été actualisées par un groupe de travail
constitué de 12 experts rhumatologues, deux représentants des associations de patients et un …

[HTML][HTML] Recommandations de la Société française de rhumatologie pour la prise en charge de la polyarthrite rhumatoïde

C Gaujoux-Viala, L Gossec, A Cantagrel… - Revue du …, 2014 - Elsevier
Cet article présente les recommandations de la Société française de rhumatologie pour la
prise en charge de la polyarthrite rhumatoïde (PR). Ces recommandations ont été élaborées …

Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician …

…, S Al-Adely, L Carmona, MI Danila, L Gossec… - Annals of the …, 2020 - ard.bmj.com
Objectives COVID-19 outcomes in people with rheumatic diseases remain poorly understood.
The aim was to examine demographic and clinical factors associated with COVID-19 …

Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported …

…, R Costello, W Costello, L Gossec… - Annals of the …, 2021 - ard.bmj.com
Objectives To determine factors associated with COVID-19-related death in people with
rheumatic diseases. Methods Physician-reported registry of adults with rheumatic disease and …

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update

…, C Gabay, J Gomez-Reino, L Gossec… - Annals of the …, 2017 - ard.bmj.com
Recent insights in rheumatoid arthritis (RA) necessitated updating the European League
Against Rheumatism (EULAR) RA management recommendations. A large international Task …

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update

…, P Emery, C Gaujoux-Viala, L Gossec… - Annals of the …, 2014 - ard.bmj.com
In this article, the 2010 European League against Rheumatism (EULAR) recommendations
for the management of rheumatoid arthritis (RA) with synthetic and biological disease-…

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update

…, P Emery, A Finckh, L Gossec… - Annals of the …, 2020 - ard.bmj.com
Objectives To provide an update of the European League Against Rheumatism (EULAR)
rheumatoid arthritis (RA) management recommendations to account for the most recent …

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs

…, M Schoels, D Aletaha, M Buch, L Gossec… - Annals of the …, 2010 - ard.bmj.com
Treatment of rheumatoid arthritis (RA) may differ among rheumatologists and currently, clear
and consensual international recommendations on RA treatment are not available. In this …

Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force

…, LC Coates, P Emery, LS Gensler, L Gossec… - Annals of the …, 2018 - ard.bmj.com
Therapeutic targets have been defined for axial and peripheral spondyloarthritis (SpA) in
2012, but the evidence for these recommendations was only of indirect nature. These …

[HTML][HTML] European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update

L Gossec, JS Smolen, S Ramiro, M De Wit… - Annals of the …, 2016 - ard.bmj.com
Background Since the publication of the European League Against Rheumatism recommendations
for the pharmacological treatment of psoriatic arthritis (PsA) in 2012, new evidence …